Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Jue Wang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Emerging Drugs|June 1, 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's diseaseHui Jue Wang, Arun Chinna-Meyyappan, Oriel J Feldman, et al.
Expert Opinion on Drug Safety|October 17, 2022
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's diseaseNathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.
Journal of Alzheimer'S Disease Reports|June 14, 2023
Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19Hui Jue Wang, Raphael W Kusumo, Alex Kiss, et al.
CNS Drugs|February 26, 2026
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysisTiffany J Pan, Hui Jue Wang, Almira Siddiqui, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsTiffany J Pan, Hui Jue Wang, Nathan Herrmann, et al.
Neurodegenerative Disease Management|November 12, 2025
Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory <i>post hoc</i> analysisHui Jue Wang, Myuri Ruthirakuhan, Ana C Andreazza, et al.
Brain Sciences|March 29, 2023
Risk of Motor Vehicle Collisions and Culpability among Older Drivers Using Cannabis: A Meta-AnalysisArun Chinna-Meyyappan, Hui Jue Wang, Kritleen K Bawa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Emerging Drugs|June 1, 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's diseaseHui Jue Wang, Arun Chinna-Meyyappan, Oriel J Feldman, et al.
Expert Opinion on Drug Safety|October 17, 2022
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's diseaseNathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.
Journal of Alzheimer'S Disease Reports|June 14, 2023
Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19Hui Jue Wang, Raphael W Kusumo, Alex Kiss, et al.
CNS Drugs|February 26, 2026
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysisTiffany J Pan, Hui Jue Wang, Almira Siddiqui, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsTiffany J Pan, Hui Jue Wang, Nathan Herrmann, et al.
Neurodegenerative Disease Management|November 12, 2025
Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory <i>post hoc</i> analysisHui Jue Wang, Myuri Ruthirakuhan, Ana C Andreazza, et al.
Brain Sciences|March 29, 2023
Risk of Motor Vehicle Collisions and Culpability among Older Drivers Using Cannabis: A Meta-AnalysisArun Chinna-Meyyappan, Hui Jue Wang, Kritleen K Bawa, et al.
Pageof 1